VT or Not VT?: That Is the Question

Circulation. 2020 Aug 11;142(6):605-607. doi: 10.1161/CIRCULATIONAHA.120.047386. Epub 2020 Aug 10.

Authors

Jeffrey Wagner¹, Jesse Fitzpatrick¹, Nora Goldschlager^{2

3}

Affiliations

¹ Department of Internal Medicine, Kaiser Foundation Hospital, San Francisco, CA (J.W., J.F.).
² Division of Cardiology, Department of Internal Medicine, Zuckerberg San Francisco General Hospital, CA (N.G.).
³ Department of Internal Medicine, University of California, San Francisco (N.G.).

PMID: 32776843
DOI: 10.1161/CIRCULATIONAHA.120.047386

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anti-Arrhythmia Agents / adverse effects*
Anti-Arrhythmia Agents / therapeutic use
Atrial Flutter / diagnosis*
Atrial Flutter / etiology
Drug-Related Side Effects and Adverse Reactions / diagnosis*
Electrocardiography / methods*
Flecainide / adverse effects*
Flecainide / therapeutic use
Humans
Male
Tachycardia, Ventricular / diagnosis
Tachycardia, Ventricular / drug therapy*
Withholding Treatment

Substances

Anti-Arrhythmia Agents
Flecainide